41 stories from 9 sources
The week in Mergers and Acquisitions
Click on a headline to see stories that shaped it.
Threads
4 threads
AbbVie and Merck announced large healthcare and life-sciences acquisitions as coverage pointed to a wider biotech spending surge. The week tied dealmaking to pipeline replacement, laboratory tools and patent-cliff pressure.
EasyJet rejected multiple Castlelake proposals, but Castlelake continued to pursue shareholders and top holders held out for a higher bid. The dispute kept the airline's valuation unresolved throughout the week.
Ari Emanuel's proposed acquisition of ATG emerged as a sizable live-entertainment bet, with later coverage extending the pursuit across Broadway and the West End. The deal would test valuations for premium theatre assets in a higher-rate market.
Paramount Skydance's roughly $110 billion takeover of Warner Bros. Discovery moved closer to completion after remedies addressed EU concerns over film distribution. The step removed a major regulatory obstacle to one of the largest media mergers.
Day’s Recap